Pivotal bioVenture Partners Investment Advisor as of Sept. 30, 2024
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 11 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 43.4 | $73M | 640k | 114.27 | |
| Inozyme Pharma (INZY) | 14.0 | $24M | 4.5M | 5.23 | |
| Arcutis Biotherapeutics (ARQT) | 11.7 | $20M | 2.1M | 9.30 | |
| Oculis Holding Ordinary Shares (OCS) | 11.6 | $20M | 1.6M | 12.26 | |
| Zenas Biopharma (ZBIO) | 6.5 | $11M | 651k | 16.92 | |
| Bioage Labs (BIOA) | 6.5 | $11M | 528k | 20.80 | |
| Exscientia Ads (EXAI) | 2.2 | $3.8M | 771k | 4.88 | |
| Rallybio Corp (RLYB) | 1.7 | $2.8M | 2.4M | 1.17 | |
| Vigil Neuroscience (VIGL) | 1.1 | $1.9M | 561k | 3.40 | |
| Bolt Biotherapeutics | 0.7 | $1.2M | 1.9M | 0.65 | |
| Io Biotech (IOBT) | 0.5 | $907k | 864k | 1.05 |
